Lina Asmar

Baylor University Medical Center

48H指数

255论文数

9.2K被引数

收录论文 43

发表时间

Outcomes After Accelerated Partial Breast Irradiation in Women With Triple Negative Subtype and Other High Risk Variables Categorized as Cautionary in The ASTRO Guidelines

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-11

OAAI

Goulding, Anabel; Asmar, Lina; Wang, Yunfei; Tole, Shannon; Barke, Lora; Widner, Jodi; Leonard, Charles

Outcomes after accelerated partial breast irradiation in high risk and women categorized as cautionary in the ASTRO guidelines

CANCER RESEARCH

IF16.6

2020-02-15

PREAI

Goulding, Anabel; Leonard, Charles; Tole, Shannon; Barke, Lora; Widner, Jodi; Asmar, Lina; Wang, Yunfei

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

NPJ BREAST CANCER

IF7.6

2019-10-28

OAAI

Paul, Devchand; Vukelja, Svetislava J.; Holmes, Frankie Ann; Blum, Joanne L.; McIntyre, Kristi J.; Lindquist, Deborah L.; Osborne, Cynthia R.; Sanchez, Ines J.; Goldschmidt, Jerome H.; Wang, Yunfei; Asmar, Lina; Strauss, Lewis; O'Shaughnessy, Joyce

Pertuzumab (P) use in first-line HER2-positive metastatic breast cancer (mBC) in US community oncology practices: Treatment patterns and outcomes

CANCER RESEARCH

IF16.6

2016-02-15

PREAI

Robert, N.; Goertz, H-P; Asmar, L.; Tseng, W-Y; Jiao, X.; Portera, C.; Yoo, B.; Patt, D.; Antao, V.

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2015-11-09

OAAI

Denduluri, Neelima; Patt, Debra A.; Wang, Yunfei; Bhor, Menaka; Li, Xiaoyan; Favret, Anne M.; Morrow, Phuong Khanh; Barron, Richard L.; Asmar, Lina; Saravanan, Shanmugapriya; Li, Yanli; Garcia, Jacob; Lyman, Gary H.

Clinical characteristics, treatment patterns, and outcomes for patients with HER2-positive metastatic breast cancer (MBC) treated with pertuzumab (P) in the first-line in a real-world setting

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-01

PREAI

Robert, N.; Goertz, H. P.; Asmar, L.; Tseng, W. Y.; Jiao, X.; Portera, C.; Yoo, B.; Patt, D.; Antao, V.

The chromosomal genomic landscape and targetable co-amplified genes in HER2 positive breast cancer patients who relapsed on an adjuvant trastuzumab chemotherapy trial

CANCER RESEARCH

IF16.6

2015-05-01

PREAI

Gunn, Shelly; McCaskill, Chris; Daley, Linda; Puskas, Agnes; Asmar, Lina; Wang, Yunfei; Jones, Stephen

Letrozole plus dasatinib improves progression-free survival (PFS) in hormone receptor-positive, HER2-negative postmenopausal metastatic breast cancer (MBC) patients receiving first-line aromatase inhibitor (AI) therapy

CANCER RESEARCH

IF16.6

2013-12-15

PREAI

Paul, D.; Vukelja, S. J.; Holmes, F. A.; Blum, J.; McIntyre, K. J.; Kumar, A. R.; Lindquist, D. L.; Osborne, C. R.; Sanchez, I. J.; Goldschmidt, J. H.; Wang, Y.; Asmar, L.; Lee, M. E.; Wu, N.; Logie, K.; O'Shaughnessy, J.

Increased risk of secondary cancers in patients with breast cancer under age 50 and the identification of non-BRCA inherited cancer syndromes using multi-gene hereditary cancer panels

CANCER RESEARCH

IF16.6

2013-12-15

PREAI

Diab, S.; Stuenke, A.; Kagey, J.; Hamlington, B.; Keiles, S.; Freivogel, M.; Asmar, L.; Langer, L.

Phase II randomized trial of weekly and every-3-week ixabepilone in metastatic breast cancer patients

BREAST CANCER RESEARCH AND TREATMENT

IF3

2013-10-29

PREAI

Smith, John W., II; Vukelja, Svetislava; Rabe, Amy; Wentworth-Hartung, Nicole; Koutrelakos, Nicholas; Shao, Spencer H.; Whittaker, Thomas; Wang, Yunfei; Asmar, Lina; McDowell, Diane Opatt; Mukhopadhyay, Pralay; O'Shaughnessy, Joyce

Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial

INVESTIGATIONAL NEW DRUGS

IF2.7

2013-10-01

PREAI

Reynolds, Craig; Spira, Alexander I.; Gluck, Larry; Mueller, Suzanne E.; Zhan, Feng; Boehm, Kristi A.; Asmar, Lina

Results of docetaxel plus oxaliplatin (DOCOX) ± cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study 多西他赛联合奥沙利铂 (DOCOX) ± 西妥昔单抗治疗转移性胃和/或胃食管交界处腺癌的结果: 一项随机2期研究的结果

EUROPEAN JOURNAL OF CANCER

IF7.1

2013-09-01

PREAI

Richards, Donald; Kocs, Darren M.; Spira, Alexander I.; McCollum, A. David; Diab, Sami; Hecker, Lanny I.; Cohn, Allen; Zhan, Feng; Asmar, Lina

Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70 years: Results of a Phase II trial (vol 31, pg 1330, 2013)

INVESTIGATIONAL NEW DRUGS

IF2.7

2013-07-06

OAAI

Reynolds, Craig; Spira, Alexander I.; Gluck, Larry; Bradie-Muller, Suzanne J.; Zhan, Feng; Boehm, Kristi A.; Asmar, Lina

Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study

ANNALS OF ONCOLOGY

IF65.4

2012-10-01

OAAI

Collea, R. P.; Kruter, F. W.; Cantrell, J. E.; George, T. K.; Kruger, S.; Favret, A. M.; Lindquist, D. L.; Melnyk, A. M.; Pluenneke, R. E.; Shao, S. H.; Crockett, M. W.; Asmar, L.; O'Shaughnessy, J.

Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer

CLINICAL COLORECTAL CANCER

IF3.2

2012-06-01

PREAI

Saltz, Leonard; Badarinath, Suprith; Dakhil, Shaker; Bienvenu, Bryan; Harker, W. Graydon; Birchfield, George; Tokaz, Laurence K.; Barrera, David; Conkling, Paul R.; O'Rourke, Mark A.; Richards, Donald A.; Reidy, Diane; Solit, David; Vakiani, Efsevia; Capanu, Marinella; Scales, Amy; Zhan, Feng; Boehm, Kristi A.; Asmar, Lina; Cohn, Allen

Phase II Trial of Ixabepilone Plus Carboplatin in Patients with Metastatic Breast Cancer: The ECLIPSE Study.

CANCER RESEARCH

IF16.6

2011-12-01

PREAI

Osborne, C.; Challagalla, J. D.; Fanning, S. R.; Eisenbeis, C. F.; Holmes, F. A.; Monaghan, G. G.; Neubauer, M. A.; Rabe, A. C.; Raja, V.; Robbins, G. J.; Taboada, C.; Vukelja, S. J.; Wilks, S. T.; Wang, Y.; Brown, J-A; Asmar, L.; O'Shaughnessy, J.

The Incidence of Febrile Neutropenia in the First Course of Adjuvant Chemotherapy with Docetaxel/Cyclophosphamide with or without Pegfilgrastim.

CANCER RESEARCH

IF16.6

2011-12-01

PREAI

Jones, S.; Paul, D.; Sedlacek, S.; Vukelja, S.; Wilks, S. T.; Stokoe, C.; Osborne, C. R.; Krekow, L.; McIntyre, K.; Holmes, F. A.; Guerra, L.; Zhan, F.; Asmar, L.; O'Shaughnessy, J.; Blum, J. L.

Randomized Phase II Trial of Fulvestrant with or without Dasatinib in Postmenopausal Patients with Hormone Receptor-Positive Metastatic Breast Cancer Previously Treated with an Aromatase Inhibitor.

CANCER RESEARCH

IF16.6

2011-12-01

PREAI

Wright, G. L.; Blum, J.; Krekow, L. K.; McIntyre, K. J.; Wilks, S. T.; Rabe, A. C.; Vukelja, S. J.; Andersen, J. C.; Wang, Y.; Asmar, L.; O'Shaughnessy, J.

A Phase III trial of fludarabine, cyclophosphamide, and rituximab vs. pentostatin, cyclophosphamide, and rituximab in B-cell chronic lymphocytic leukemia

INVESTIGATIONAL NEW DRUGS

IF2.7

2011-09-16

PREAI

Reynolds, Craig; Di Bella, Nicholas; Lyons, Roger M.; Hyman, William; Richards, Donald A.; Robbins, Gerald J.; Vellek, Mark; Boehm, Kristi A.; Zhan, Feng; Asmar, Lina

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

LANCET

IF88.5

2011-01-01

277

PREAI

van de Velde, Cornelis J. H.; Rea, Daniel; Seynaeve, Caroline; Putter, Hein; Hasenburg, Annette; Vannetzel, Jean-Michel; Paridaens, Robert; Markopoulos, Christos; Hozumi, Yasuo; Hille, Elysee T. M.; Kieback, Dirk G.; Asmar, Lina; Smeets, Jan; Nortier, Johan W. R.; Hadji, Peyman; Bartlett, John M. S.; Jones, Stephen E.

研究方向